nitecapone

Known as: 3-(3,4-dihydroxy-5-nitrobenzylidine)-2,4-pentanedione 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1990-2012
0519902012

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
We attempted to characterize a spinal neuronal correlate of painful neuropathy induced by diabetes mellitus (DM). Pain behavior… (More)
Is this relevant?
1997
1997
Purpose. Nitrocatechol COMT inhibitors are a new class of bioactive compounds, for which glucuronidation is the most important… (More)
Is this relevant?
1995
1995
The effect of nitecapone (3[(3,4-dihydroxy-5-nitrophenyl) methylene]-2,4-pentanedione) on lipid peroxidation in guinea pig liver… (More)
Is this relevant?
1994
1994
Nitecapone [3-(3,4-dihydroxy-5-nitrobenzylidene)-2,4-pentanedione], is a scavenger of nitric oxide produced in vitro. It reduced… (More)
Is this relevant?
1993
1993
Metabolites of nitecapone [3-(3,4-dihydroxy-5-nitrobenzylidene)-2,4-pentanedione], a potent catechol-O-methyltransferase… (More)
Is this relevant?
1993
1993
1. The effect of a new antiulcer agent, nitecapone, on the synthesis and secretion of sulfomucin in gastric mucosa was… (More)
Is this relevant?
1992
1992
Nitecapone [3-(3,4-dihydroxy-5-nitrophenyl)methylene-2,4-pentanedione] [OR-462] is a catechol-O-methyltransferase inhibitor with… (More)
Is this relevant?
1992
1992
PET studies were performed to investigate the effects of a new cathechol-O-methyltransferase (COMT) inhibitor, nitecapone (OR-462… (More)
Is this relevant?
1991
1991
The effect of increasing single oral doses of the novel catechol-O-methyltransferase (COMT) inhibitor, nitecapone, on enzyme… (More)
  • figure 2
  • table 2
Is this relevant?
1990
1990
A new catechol-O-methyltransferase (COMT) inhibitor, nitecapone, was given in increasing doses of 0-100 mg concomitantly with L… (More)
Is this relevant?